376
Participants
Start Date
May 10, 2020
Primary Completion Date
August 18, 2022
Study Completion Date
September 2, 2022
Gefapixant
Administered twice daily as an oral tablet of 45 mg
Placebo
Administered twice daily as a placebo oral tablet matching gefapixant
Praxis an der Oper ( Site 0912), Berlin
Clinica Ricardo Palma ( Site 0601), San Isidro
Asociacion Civil por la Salud ( Site 0602), Lima
Hospital Nacional Arzobispo Loayza ( Site 0607), Lima
Hospital Clinico Universitario de Santiago ( Site 1805), Santiago de Compostela
Temple University ( Site 0003), Philadelphia
Clinica Belen ( Site 0604), Piura
"Private Small-Scale Enterprise Medical Centre Pulse ( Site 2809)", Vinnytsia
Chesapeake Clinical Research, Inc ( Site 0022), White Marsh
Tidewater Physician Multispecialty Group, PC ( Site 0028), Williamsburg
TPMG Clinical Research ( Site 0025), Newport News
Wonju Severance Christian Hospital ( Site 1502), Wŏnju
Hospital General Universitario Gregorio Maranon ( Site 1808), Madrid
Clinical Research of Gastonia ( Site 0016), Gastonia
American Health Research ( Site 0027), Charlotte
PMG Research of Wilmington ( Site 0004), Wilmington
Pneumologicum im Suedstadtforum ( Site 0908), Hanover
Florida Pulmonary Research Institute, LLC ( Site 0008), Winter Park
Lenus Research & Medical Group Llc ( Site 0007), Sweetwater
Well Pharma Medical Research, Corp. ( Site 0040), Miami
Health Awareness, Inc. ( Site 0038), Jupiter
Carmel Medical Center ( Site 1104), Haifa
Zentrum fuer ambulante pneumologische Forschung Marburg GbR ( Site 0900), Marburg
"Municipal enterprise 1st City clinical hospital of Poltava -Internal medicine department ( Site 281", Poltava
Volyn Regional Clinical Hospital ( Site 2816), Lutsk
Jeonbuk National University Hospital ( Site 1507), Jeonju
Ballenberger Freytag Wenisch Institut fuer klinische Forschung GmbH ( Site 0905), Neu-Isenburg
Odesa regional clinical hospital ( Site 2804), Odesa
City Polyclinic N20 ( Site 2806), Odesa
University of Missouri ENT & Allergy Center ( Site 0010), Columbia
Diagnostics Research Group ( Site 0013), San Antonio
Praxis Dr. Wehgartner-Winkler ( Site 0906), Augsburg
Albuquerque Clinical Trials ( Site 0019), Albuquerque
Alliance for Multispecialty Research, LLC ( Site 0035), Las Vegas
Center for Clinical Trials, LLC ( Site 0021), Paramount
Bellingham Asthma & Allergy ( Site 0006), Bellingham
Medplus Medicina Prepagada ( Site 0402), Bogotá
Open Joint Stock Company Clinical and Diagnostic Center Euromedservice ( Site 1466), Moscow
Krasnogorsk City Hospital Number 1 ( Site 1470), Krasnogorsk
SBCIH of the Yaroslavl region Central city hospital ( Site 1428), Yaroslavl
Medi Kom ( Site 1456), Saint Petersburg
Limited Liability Company Kurator ( Site 1424), Saint Petersburg
SEIHPE Saint Petersburg SMU ( Site 1434), Saint Petersburg
Healthy Medical Center S.A.S ( Site 0404), Zipaquirá
RSBHI Belgorod regional clinical hospital of Prelate Ioasafa ( Site 1416), Belgorod
Voronezh Regional Clinical Hospital #1 ( Site 1440), Voronezh
Saratov City Clinical Hospital 2 n.a. V.I. Razumovsky ( Site 1452), Saratov
State health Agency Ulyanovsk regional clinical hospital ( Site 1414), Ulyanovsk
GBUZ Regional Clinical Hospital 3 ( Site 1420), Chelyabinsk
Perm Clinical Center of the Federal Medical and Biological Agency ( Site 1450), Perm
Family Clinic ( Site 1464), Yekaterinburg
City Clinical Hospital of Emergency Care #2 ( Site 1448), Novosibirsk
Clinic of FSBEI HE OmSMU of Minzdrav ( Site 1438), Omsk
City Clinical Hospital No. 3 them. M. A. Podgorbunskogo ( Site 1400), Kemerovo
Rabin Medical Center ( Site 1102), Petah Tikva
Chaim Sheba Medical Center ( Site 1101), Ramat Gan
Sourasky Medical Center ( Site 1100), Tel Aviv
Kaplan Medical Center ( Site 1103), Rehovot
Shaare Zedek Medical Center ( Site 1107), Jerusalem
Hadassah Ein Karem Jerusalem ( Site 1108), Jerusalem
Paul A. Shapero, MD ( Site 0037), Bangor
AAPRI Clinical Research Institute ( Site 0031), Warwick
Centro Medico Dra De Salvo ( Site 0300), Buenos Aires
Investigaciones en Patologias Respiratorias ( Site 0302), San Miguel de Tucumán
Fundacion Centro de Investigacion Clinica CIC ( Site 0401), Medellín
Universidad Pontificia Bolivariana - Clinica Universitaria Bolivariana ( Site 0408), Medellín
Bethel Soluciones Medicas S.A. ( Site 0506), Guatemala City
Centro de Investigaciones Clinicas de Latinoamerica S.A. - CELAN ( Site 0500), Guatemala City
Clinica Medica Especializada en Neumologia y Tisiologia ( Site 0504), Guatemala City
Clinica Medica Especializada en Neumologia ( Site 0502), Guatemala City
Private Clinic ( Site 0505), Guatemala City
Clinica Privada Dr. Jose Francisco Flores Lopez ( Site 0503), Guatemala City
The Catholic University of Korea Eunpyeong St Mary s Hospital ( Site 1506), Seoul
Konkuk University Medical Center ( Site 1504), Seoul
Asan Medical Center ( Site 1505), Seoul
Hospital Parc Tauli ( Site 1806), Sabadell
Hospital Clinic i Provincial de Barcelona ( Site 1804), Barcelona
F.G.Yanovskyy Institute of Phthisiology and Pulmonology ( Site 2808), Kyiv
F.G.Yanovskyy Institute of Phthisiology and Pulmonology ( Site 2819), Kyiv
SE Road Clinical Hospital 2 of Kyiv station ( Site 2812), Kyiv
SE O.S.Kolomiychenko Institute of Otolaryngology of NAMS of Ukraine ( Site 2817), Kyiv
Medical Center of LLC Medical Clinic Blahomed ( Site 2815), Kyiv
GP Direct ( Site 2714), Harrow
West Walk Surgery ( Site 2700), Yate
Medinova Lakeside Dedicated Research Centre ( Site 2712), Corby
Kings College Hospital NHS Foundation Trust ( Site 2702), London
Accellacare South London Quality Research Centre ( Site 2706), Orpington
Wokingham Medical Centre ( Site 2708), Wokingham
Medinova North London Dedicated Research Centre ( Site 2705), Northwood
Medinova Warwickshire Dedicated Research Centre ( Site 2715), Coventry
Merck Sharp & Dohme LLC
INDUSTRY